ACA
Avoro Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286M | Buy |
6,555,555
+95,555
| +1% | +$4.17M | 5.01% | 6 |
|
|
2025
Q1 | $177M | Buy |
6,460,000
+1,310,000
| +25% | +$35.9M | 2.76% | 11 |
|
|
2024
Q4 | $207M | Buy |
5,150,000
+650,000
| +14% | +$26.1M | 2.93% | 14 |
|
|
2024
Q3 | $213M | Buy |
4,500,000
+611,112
| +16% | +$28.9M | 3.11% | 12 |
|
|
2024
Q2 | $116M | Hold |
3,888,888
| – | – | 1.55% | 18 |
|
|
2024
Q1 | $156M | Buy |
3,888,888
+113,888
| +3% | +$4.58M | 1.82% | 19 |
|
|
2023
Q4 | $96.1M | Sell |
3,775,000
-80,000
| -2% | -$2.04M | 1.33% | 18 |
|
|
2023
Q3 | $53.6M | Hold |
3,855,000
| – | – | 0.84% | 19 |
|
|
2023
Q2 | $88.6M | Hold |
3,855,000
| – | – | 1.2% | 18 |
|
|
2023
Q1 | $114M | Buy |
3,855,000
+5,000
| +0.1% | +$148K | 1.69% | 16 |
|
|
2022
Q4 | $96.1M | Buy |
3,850,000
+1,680,770
| +77% | +$42M | 1.44% | 17 |
|
|
2022
Q3 | $47.2M | Buy |
2,169,230
+909,230
| +72% | +$19.8M | 0.87% | 21 |
|
|
2022
Q2 | $24.8M | Buy |
1,260,000
+443,500
| +54% | +$8.73M | 0.49% | 28 |
|
|
2022
Q1 | $34.6M | Buy |
816,500
+266,500
| +48% | +$11.3M | 0.63% | 24 |
|
|
2021
Q4 | $34.9M | Buy |
550,000
+94,250
| +21% | +$5.98M | 0.59% | 27 |
|
|
2021
Q3 | $26.8M | Buy |
+455,750
| New | +$26.8M | 0.42% | 33 |
|
|
2020
Q4 | – | Sell |
-49,400
| Closed | -$1.6M | – | 46 |
|
|
2020
Q3 | $1.6M | Buy |
+49,400
| New | +$1.6M | 0.02% | 46 |
|